THERAPEUTIC CLASS

Quality improvement in neurology Epilepsy Quality Measurement Set 2017 update

---

Epilepsy is a common condition in the United States. It is estimated that 1.2% of the populationrnor 3.4 million people have epilepsy. This figure may be underestimated because of potentialrnrepercussions and stigma in disclosing epilepsy.1 Studies have shown that people with epilepsyrnare more likely to be unemployed or unable to work, have lower annual household incomes, bernobese and physically inactive, and be less likely to marry.2,3 People with epilepsy can have poorrnoverall health status, impaired intellectual and physical functioning, elevated risk of accidentsrnand injuries, and negative side effects from antiseizure medications.2,3 It is estimated the annualrndirect medical cost of epilepsy in the United States is $9.6 billion; combined with indirect costs,rnthe total rises to $15.5 billion yearly

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Oncology
Central Nervous System
Lepsio
Docetaxel
Carboplatin
Cisplatin
Mertigo
Vastigo

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment